Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 2, 2006, Pages

  Pepperell, John R ^a,b,c   Nemeth, Gabor ^a,d   Yamada, Yuji ^a,e   Naftolin, Frederick ^a   Merino, Maricruz ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c WOMEN AND INFANTS HOSPITAL   (United States)

^d UNIVERSITY OF SZEGED   (Hungary)

^e NIHON UNIVERSITY   (Japan)

Author keywords

Angiotensin antagonist; Protease inhibitor; Signaling

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN II; ANGIOTENSIN III; ANGIOTENSIN[1-7]; BENZYLSULFONYL FLUORIDE; CYCLIC AMP; CYSTEINE PROTEINASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; LUTEINIZING HORMONE; PARACHLOROMERCURYLSULFONYL ACID; PROLYL ENDOPEPTIDASE INHIBITOR; QUINAPRIL; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; Z PROPROLINAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS LUTEUM; CYTOPLASM; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SYNTHESIS; LUTEAL CELL; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; RAT; STEROIDOGENESIS;

EID: 33745839274     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00205.2005     Document Type: Article

References (84)

1. 2α, and steroid hormones from bovine mature follicles in vivo. Biol Reprod 63: 1253-1261, 2000.
2. Aguilera G, Millan MA, and Harwood JP. Angiotensin receptors in the gonads. Am J Hypertens 2: 395-402, 1989.
3. Benter IF, Diz DI, and Ferrario CM. Cardiovascular actions of angiotensin-(1-7). Peptides 14: 679-684, 1993.
4. Bramucci M, Miano A, Gobbetti A, Zerani M, Quassinti L, Maccari E, Murri O, and Amici D. Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II. Am J Physiol Regul Integr Comp Physiol 273: R2089-R2096, 1997.
5. Brosnihan KB, Li P, Tallant EA, and Ferrario CM. Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res 31: 227-234, 1998.
6. Brunswig-Spickenheier B and Mukhopadhyay AK. Inhibitory effects of a tumor-promoting phorbol ester on luteinizing hormone-stimulated renin and prorenin production by cultured bovine thecal cells. Endocrinology 127: 2157-2165, 1990.
7. Carmel A, Ehrlich-Rogozinsky S, and Yaron A. A fluorimetic assay for angiotensin-I converting enzyme in human serum. Clin Chim Acta 93: 215-220, 1979.
8. Chappel MC, Tallant EA, Brosnihan KB, and Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides 11: 375-380, 1990.
9. Chappell MC, Brosnihan KB, Diz DI, and Ferrario CM. Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem 264: 16518-16523, 1989.
10. scc and 3β-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells. J Biol Chem 272: 7899-7907, 1997.
11. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, and Timmermans PBMWM. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 165: 196-203, 1989.
12. Cohen DM, Evans DB, Ryan MJ, and Kaplan HR. Quinapril. In: New Drugs Annual: Cardiovascular Drugs, edited by Sciabine A. New York: Raven, 1985, p. 71-84.
13. Costa AP, Fagundes-Moura CR, Pereira VM, Silva LF, Vieira MA, Santos RA, and Dos Reis AM. Angiotensin-(1-7): a novel peptide in the ovary. Endocrinology 144: 1942-1948, 2003.
14. Cushman DW and Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 20: 1637-1648, 1971.
15. Daud AI, Bumpus FM, and Husain A. Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation. Endocrinology 126: 2927-2935, 1990.
16. Diz DI and Pirro NT. Differential actions of angiotensin II and angiotensin-(1-7) on transmitter release. Hypertension 19, Suppl 2: II41-II48, 1992.
17. Eggena P, Zhu JH, Clegg K, and Barret JD. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 22: 496-501, 1993.
18. Feral C, Benhaim A, and Leymarie P. Angiotensin II receptor type 1 on granulosa and thecal cells of rabbit preovulatory follicles. Biochim Biophys Acta 1284: 221-226, 1996.
19. Fernandez LA, Twicler J, and Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 105: 141-145, 1985.
20. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla M, Milsted A, and Tallant EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension 18, Suppl: III126-III133, 1991.
21. Glorioso N, Atlas SA, Laragh JH, Jewelewicz R, and Sealey JJE. Prorenin in high concentrations in human ovarian follicular fluid. Science 233: 1422-1424, 1986.
22. Grasso P and Reichert LE Jr. The effects of aprotinin on follicle-stimulating hormone binding and signal transduction in bovine calf testis. Endocrinology 125: 117-125, 1989.
23. Grover GJ, Sleph PG, Dzwonczyk S, Wang P, Fung W, Tobias D, and Cushman DW. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection. J Pharmacol Exp Ther 257: 919-929, 1991.
24. Haller H, Lindschau C, Quass P, and Luft FC. Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 10, Suppl 11: S75-S83, 1999.
25. Hayashi K, Miyamoto A, Berisha B, Kosmann MR, Okuda K, and Schams D. Regulation of angiotensin II production and angiotensin receptors in microvascular endothelial cells from bovine corpus luteum. Biol Reprod 62: 162-167, 2000.
26. 1A receptors. Am J Physiol Renal Physiol 277: F303-F311, 1999.
27. 2 recognition sites in bovine adrenal cortex. Eur J Pharmacol 219: 319-322, 1992.
28. Johnson MC, Vega M, Vantman D, Troncoso JL, and Devoto L. Regulatory role of angiotensin II on progesterone production by cultured human granulosa cells. Expression of angiotensin II type-2 receptor. Mol Hum Reprod 3: 663-668, 1997.
29. Katugampola SD and Davenport AP. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart. Clin Sci (Lond) 102: 15-21, 2002.
30. Kessler SP, Rowe TM, Blendy JA, Erickson RP, and Sen GC. A cyclic AMP response element in the angiotensin-converting enzyme gene and the transcription factor CREM are required for transcription of the mRNA for the testicular isozyme. J Biol Chem 273: 9971-9975, 1998.
31. Kiron MA and Soffer RL. Purification and properties of a soluble angiotensin-II binding protein from rat liver. J Biol Chem 264: 4138-4142, 1989.
32. Kobayashi S, Acosta TJ, Ozawa T, Hayashi K, Berisha B, Ohtani M, Schams D, and Miyamoto A. Intraluteal release of angiotensin II and progesterone in vivo during corpora lutea development in the cow: effect of vasoactive peptides. Biol Reprod 66: 174-179, 2002.
33. 2α. J Endocrinol 170: 369-380, 2001.
34. Kotani E, Sugimoto M, Kamata H, Fujii N, Saitoh M, Usuki S, Kubo T, Song K, Miyazaki M, Murakami K, and Miyazaki H. Biological roles of angiotensin II via its type 2 receptor during rat follicle atresia. Am J Physiol Endocrinol Metab 276: E25-E33, 1999.
35. Kuo TC, Endo K, Dharmarajan AM, Miyazaki T, Atlas SJ, and Wallach EE. Direct effect of angiotensin II on in-vitro perfused rabbit ovary. J Reprod Fertil 92: 469-474, 1991.
36. Lepers A, Cacan R, and Verbert A. Permeabilized cells as a way of gaining access to intracellular organelles: an approach to glycosylation reactions. Biochimie 72: 1-5, 1990.
37. Li XM, Juorio AV, and Murphy BD. Angiotensin II interferes with steroidogenesis in porcine granulosa cells. Biol Reprod 53: 791-799, 1995.
38. Lightman A, Jones C, McLusky NJ, Palumbo A, and Naftolin F. Immunocytochemical localization of angiotensin II immunoreactivity and demonstration of angiotensin II binding in the rat ovary. Am J Obstet Gynecol 159: 526-530, 1988.
39. Lightman A, Tarlatzis BC, Rzasa PJ, Culler MD, Caride VJ, Negro-Villar AF, Lennard D, DeCherney AH, and Naftolin F. The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotrophin stimulated and unstimulated human follicular fluid. Am J Obstet Gynecol 156: 808-814, 1987.
40. Loret de Mola JR, Goldfarb JM, Hecht BR, Babbo CJ, and Friedlander MA. Gonadotropins induce higher active renin levels in the follicular fluid of normal and hyperstimulated cycles. Gynecol Endocrinol 13: 155-160, 1999.
41. Machado RD, Santos RA, and Andrade SP. Mechanisms of angiotensin-(1-7)- induced inhibition of angiogenesis. Am J Physiol Regul Integr Comp Physiol 280: R994-R1000, 2001.
42. McAuley ME, Raven PW, and Vinson GP. Effects of protease inhibitors on adenylate cyclase activation and aldosterone production in rat adrenal zona glomerulosa cells. Cell Biochem Funct 3: 277-281, 1985.
43. McMurray J and Davie AP. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 106: e147, 2002.
44. Mele PG, Dada LA, Paz C, Cymeryng CB, Cornejo Maciel MF, Neuman MI, Finkielstein CV, Mendez CF, and Podesta EJ. Site of action of proteinases in the activation of steroidogenesis in rat adrenal gland. Biochim Biophys Acta 1310: 260-268, 1996.
45. Merrill DC, Karoly M, Chen K, Ferrario CM, and Brosnihan KB. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 18: 239-245, 2002.
46. Morris RS, Paulson RJ, Lindheim SR, Legro RS, Lobo RA, and Sauer MV. Angiotensin-converting enzyme inhibition reverses luteal phase steroid production in oocyte donors. Fertil Steril 63: 854-858, 1995.
47. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, and Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesentric and hindquarters vascular beds. Eur J Pharmacol 234: 35-42, 1993.
48. Palumbo A, Pourmotabbed G, Carcangiu ML, Andrade-Gordon P, Roa L, DeCherney AH, and Naftolin F. Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil Steril 60: 280-284, 1993.
49. Pedersen RC. Steroidogenesis activator polypeptide (SAP) in the rat ovary and testis. J Steroid Biochem 27: 731-735, 1987.
50. Pellicer A, Palumbo A, DeCherney AH, and Naftolin F. Blockade of ovulation by an angiotensin antagonist. Science 240: 1660-1661, 1988.
51. 2α is not mediated by elevated cytosolic calcium levels in rat luteal cells. Endocrinology 125: 144-151, 1989.
52. Pepperell JR, Yamada Y, Nemeth G, Palumbo A, and Naftolin F. The ovarian renin angiotensin system: a paracrine-intracrine regulator of ovarian function. In: Tissue Renin Angiotensin Systems, edited by Mukhopadhyay AK and Raizada MK. New York: Plenum, 1995, p. 379-389.
53. Peterson CM, Zhu C, Mukaida T, Butler TA, Woessner JF Jr, and LeMaire WJ. The angiotensin II antagonist, saralasin, inhibits ovulation in the perfused rat ovary. Am J Obstet Gynecol 168: 242-245, 1993.
54. Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C, Sandri F, Pieri F, Leoncini L, Falini B, Brown RW, and Chirala R. Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 183: 116-123, 1997.
55. Pon LA and Orme-Johnson NR. Acute stimulation of steroidogenesis in corpus luteum and adrenal cortex by peptide hormones. Rapid induction of a similar protein in both tissues. J Biol Chem 261: 6594-6599, 1986.
56. Privalle CT, Crivello JF, and Jefcoate CR. Regulation of intramitochondrial cholesterol transfer to side chain cleavage cytochrome P-450 in rat adrenal gland. Proc Natl Acad Sci USA 80: 702-706, 1983.
57. Regoli D, Park WK, and Rioux F. Pharmacology of angiotensin. Pharmacol Rev 26: 69-123, 1974.
58. Rennert H, Chang YJ, and Strauss JF III. Intracellular Cholesterol Dynamics in Steroidogenic Cells. New York: Raven, 1993.
59. Sahin Y, Kontas O, Muderris II, and Cankurtaran M. Effects of angiotensin converting enzyme inhibitor cilazapril and angiotensin II antagonist saralasin in ovarian hyperstimulation syndrome in the rabbit. Gynecol Endocrinol 11: 231-236, 1997.
60. Santos RA, Brosnihan KB, Chappell MC, Pesquero J, Chernicky CL, Greene LJ, and Ferrario CM. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension 11: I153-I157, 1988.
61. Santos RA, Brosnihan KB, Jacobsen DW, DiCorleto PE, and Ferrario CM. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension 19, Suppl 2: II56-II61, 1992.
62. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, and Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100: 8258-8263, 2003.
63. Sealey JE, Atlas SA, Glorioso N, Manapat H, and Laragh JH. Cyclical secretion of prerenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone. Proc Natl Acad Sci USA 82: 8705-8709, 1985.
64. Shirasawa Y, Osawa T, and Hirashima A. Molecular cloning and characterization of prolyl endopeptidase from human T cells. J Biochem (Tokyo) 115: 724-729, 1994.
65. Speth RC and Husain A. Distribution of angiotensin-converting enzyme and angiotensin II-receptor binding sites in the rat ovary. Biol Reprod 38: 695-702, 1988.
66. Sterling D, Magness RR, Stone R, Waterman MR, and Simpson ER. Angiotensin II inhibits LH-stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture. J Biol Chem 265: 5-8, 1990.
67. Stocco DM and Ascoli M. The use of genetic manipulation of MA-10 Leydig tumor cells to demonstrate the role of mitochondrial proteins in the acute regulation of steroidogenesis. Endocrinology 132: 959-967, 1993.
68. Stocco DM and Sodeman TC. The 30-kDa mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cells are processed from larger precursors. J Biol Chem 266: 19731-19738, 1991.
69. Tallant EA, Diz DI, and Ferrario CM. State-of-the-Art lecture. Anti-proliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension 34: 950-957, 1999.
70. Tang SS and Dzau VJ. Partial purification of a prorenin activating enzyme in the aortic wall. Clin Exp Hypertens A 10: 1251-1257, 1988.
71. Tang SS, Rogg H, Schumacher R, and Dzau VJ. Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology 131: 374-380, 1992.
72. 2+] in permeabilized HSY cells. J Biol Chem 271: 30904-30908, 1996.
73. Thomas JP, Dorflinger LJ, and Behrman HR. Mechanism of the rapid antigonadotropic action of prostaglandins in cultured luteal cells. Proc Natl Acad Sci USA 75: 1344-1348, 1978.
74. Vahouny GV, Chanderbhan R, Noland BJ, Irwin D, Dennis P, Lambeth JD, and Scallen TJ. Sterol carrier protein2. Identification of adrenal sterol carrier protein2 and site of action for mitochondrial cholesterol utilization. J Biol Chem 258: 11731-11737, 1983.
75. Velletri PA, Aquilano DR, Bruckwick E, Tsai-Morris CH, Dufau ML, and Lovenberg W. Endocrinological control and cellular localization of rat testicular angiotensin-converting enzyme. Endocrinology 116: 2516-2522, 1985.
76. Wassler M, Westman J, and Fries E. Permeabilization of hepatocytes by a saponin and the effects of dextran. Eur J Cell Biol 51: 252-258, 1990.
77. Whitebread S, Mele M, Kamber B, and De Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor sub-types. Biochem Biophys Res Commun 163: 284-291, 1989.
78. Wong PC, Price WAJ, Chiu AT, Thoolen MJMC, Duncia JV, Johnson AL, and Timmermans PBMWM. Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803. Hypertension 13: 489-497, 1989.
79. 2α in cultured rat luteal cells (Abstract). Biol Reprod 50: 116, 1994.
80. Yamakawa N, Shimeno H, Soeda S, and Nagamatsu A. Inhibition of proline endopeptidase activity by acyl-coenzyme A esters. Biochim Biophys Acta 1037: 302-306, 1990.
81. Yamamoto K, Chappell MC, Brosnihan KB, and Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.42411) in spontaneously hypertensive rats. Hypertension 19: 692-696, 1992.
82. Yoshimura Y. The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol 18: 247-291, 1997.
83. 2 receptor subtype. Endocrinology 137: 1204-1211, 1996.
84. Yoshimura Y, Karube M, Koyama N, Shiokawa S, Nanno T, and Nakamura Y. Angiotensin II directly induces follicle rupture and oocyte maturation in the rabbit. FEBS Lett 307: 305-308, 1992.